1 / 20

Per-Ulf Tunn, D. Andreou , S. Fehlberg, M. Werner, P. Reichardt

Chondrosarcoma of Bone: Survival Analysis and Prognostic Factors in a Series of 155 Patients Treated at a Single Institution. 15 th Annual CTOS Meeting, Miami Beach, FL. Per-Ulf Tunn, D. Andreou , S. Fehlberg, M. Werner, P. Reichardt. Department of Orthopedic Oncology Chair: P.-U. Tunn, MD

yule
Download Presentation

Per-Ulf Tunn, D. Andreou , S. Fehlberg, M. Werner, P. Reichardt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chondrosarcoma of Bone: Survival Analysis and Prognostic Factors in a Series of 155 Patients Treated at a Single Institution 15th Annual CTOS Meeting, Miami Beach, FL Per-Ulf Tunn, D. Andreou, S. Fehlberg, M. Werner, P. Reichardt Department of Orthopedic Oncology Chair: P.-U. Tunn, MD Sarcoma Center Berlin-Brandenburg HELIOS Klinikum Berlin-Buch, Germany

  2. Chondrosarcoma of bone • resistant to standard CT or RT • cornerstone of treatment:  adequate surgery • novel therapeutic approaches: • tyrosine kinase inhibitors • bisphosphonates • proton beam radiotherapy Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  3. Patients and Methods • study design: retrospective analysis • number of patients: 155 (94 men, 61 women) • time period: 1975 - 2005 • mean age: 47.8 years (range, 12 – 79) • mean follow-up: 79.9 months (range, 6 – 337) Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  4. Patients and Methods • tumor localization: lower extremity n = 62 pelvic girdle n = 54 upper extremity n = 29 axial skeleton n = 10 • mean tumor volume: 470.0 cm3(range, 0.2 to 8424) • pathological fracture: lower extremity n = 8 upper extremity n = 5 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  5. Patients and Methods • grading: G1 n = 75 G2 n = 56 G3 n = 24 • surgical treatment: limb-sparing n = 100 ablative n = 45 • surgical margins: wide n = 121 marginal n = 8 intralesional n = 26 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  6. Results Overall survival Event-free survival Time in months Time in months Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  7. Results – tumor localization Overall survival Event-free survival extremities (CE) CE axial skeleton and pelvis (CAP) CAP Time in months Time in months p = 0.075 p = 0.114 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  8. Results – age and gender Overall survival Overall survival age ≤ 40 women men age > 40 Time in months Time in months p < 0.001 p = 0.295 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  9. Results – local recurrence Overall survival Overall survival CE – no local recurrence CAP – no local recurrence CE – local recurrence CAP – local recurrence Time in months Time in months p < 0.001 p = 0.017 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  10. Results – metastasis Overall survival following metastatic disease Overall survival no metastasis further treatment best supportive care metastasis Time in months Time in months p < 0.001 p = 0.002 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  11. Results – tumor grading Overall survival Event-free survival G1 G1 G2 G2 G3 G3 Time in months Time in months p < 0.001 p < 0.001 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  12. Results – tumor grading Overall survival – CAP Overall survival – CE G1 G1 G2 G2 G3 G3 Time in months Time in months p = 0.107 G1 vs. G3: p = 0.034 p < 0.001 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  13. Results – pathological fracture lower extremity Overall survival p < 0.001 no pathological fracture upper extremity pathological fracture Time in months p = 0.747 p = 0.028 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  14. Results – surgical margins CAP group Overall survival marginal intralesional p < 0.001 p = 0.530 CE group wide Time in months p = 0.409 p = 0.747 p = 0.422 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  15. Results – surgical margins CAP group Event-free survival p = 0.036 wide CE group marginal intralesional Time in months p = 0.109 wide vs. intralesional: p = 0.019 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  16. Results – tumor stage Overall survival Event-free survival IA IB IA IIA IIA IB IIB IIB Time in months Time in months p = 0.001 p = 0.012 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  17. Results – tumor stage Overall survival – CE group Overall survival – CAP group IA IIA IB IA IB IIB IIB IIA Time in months Time in months p < 0.001 p = 0.166 Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  18. Conclusions – negative prognostic factors • age over 40 • local recurrence • systemic metastasis • high grade • pathological fracture at diagnosis (lower extremity) Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  19. Conclusions – quality of surgical margins • no influence on overall survival • decreased event-free survival for intralesional resections only in patients with tumors of the axial skeleton or pelvis •  intralesional resections of otherwise inoperable tumors could be justified Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

  20. Conclusions – AJCC staging system • no correlation with oncological outcome in patients with tumors of the axial skeleton or pelvis • if these results are confirmed in other studies, the development of a separate staging system for these tumors might be warranted Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin, Germany

More Related